Syros Pharmaceuticals, Inc. - common stock (SYRS): Price and Financial Metrics

Syros Pharmaceuticals, Inc. - common stock (SYRS)

Today's Latest Price: $9.17 USD

0.20 (2.23%)

Updated Sep 25 4:00pm

Add SYRS to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 233 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

SYRS Stock Summary

  • With a price/sales ratio of 63.27, Syros Pharmaceuticals Inc has a higher such ratio than 96.39% of stocks in our set.
  • With a year-over-year growth in debt of 150.21%, Syros Pharmaceuticals Inc's debt growth rate surpasses 90.38% of about US stocks.
  • As for revenue growth, note that SYRS's revenue has grown 198.65% over the past 12 months; that beats the revenue growth of 96.84% of US companies in our set.
  • Stocks that are quantitatively similar to SYRS, based on their financial statements, market capitalization, and price volatility, are CNCE, AGIO, DRNA, RGNX, and GLYC.
  • SYRS's SEC filings can be seen here. And to visit Syros Pharmaceuticals Inc's official web site, go to
SYRS Daily Price Range
SYRS 52-Week Price Range

SYRS Stock Price Chart Technical Analysis Charts

SYRS Price/Volume Stats

Current price $9.17 52-week high $14.69
Prev. close $8.97 52-week low $4.26
Day low $8.90 Volume 301,184
Day high $9.48 Avg. volume 330,831
50-day MA $11.41 Dividend yield N/A
200-day MA $8.85 Market Cap 419.64M

Syros Pharmaceuticals, Inc. - common stock (SYRS) Company Bio

Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing medicines that control genes to transform the lives of patients with cancer, immune-mediated diseases, and other diseases. The company was founded in 2011 and is based in Cambridge, Massachusetts.

SYRS Latest News Stream

Event/Time News Detail
Loading, please wait...

SYRS Latest Social Stream

Loading social stream, please wait...

View Full SYRS Social Stream

Latest SYRS News From Around the Web

Below are the latest news stories about Syros Pharmaceuticals Inc that investors may wish to consider to help them evaluate SYRS as an investment opportunity.

Who Has Been Buying Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Shares?

It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be...

Yahoo | September 10, 2020

Syros Pharmaceuticals to Present at Cantor Virtual Global Healthcare Conference

Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that its Chief Executive Officer, Nancy Simonian, M.D., will present a corporate overview at the Cantor Virtual Global Healthcare Conference. Details are as follows:

Yahoo | September 10, 2020

Syros Announces Appointment of S. Gail Eckhardt, M.D., to its Board of Directors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today announced the appointment of S. Gail Eckhardt, M.D., to the Company’s Board of Directors. Dr. Eckhardt is a highly respected oncologist and a leader in targeted oncology drug development. “Gail brings tremendous vision and experience in translational and clinical research, with a focus on combining molecularly targeted agents to the underl

Business Wire | September 9, 2020

The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) Avenue Therapeutics Inc (NASDAQ: ATXI ) Checkmate Pharmaceuticals Inc (NASDAQ: CMPI ) DarioHealth Corp (NASDAQ: DRIO ) iTeos Therapeutics Inc (NASDAQ: ITOS ) Merit Medical Systems, Inc. (NASDAQ: MMSI ) Natera Inc (NASDAQ: NTRA ) Nurix Therapeutics Inc (NASDAQ: NRIX ) Otonomy Inc (NASDAQ: OTIC ) Pacific Biosciences of California Inc (NASDAQ: PACB ) Pacira Biosciences Inc (NASDAQ: PCRX ) PDL BioPharma Inc (NASDAQ: PDLI ) Principia Biopharma Inc (NASDAQ: PRNB ) Qiagen NV (NYSE: QGEN ) Shockwave Medical Inc (NASDAQ: SWAV ) Silk Road Medical Inc (NASDAQ: SILK ) Syros Pharmaceuticals Inc (NASDAQ: SYRS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 18) Acorda Therapeutics Inc (NASDAQ: ACOR ) Alector Inc (NASDAQ: AL...

Benzinga | August 19, 2020

Syros Pharmaceuticals, Inc. (SYRS) CEO Nancy Simonian on Q2 2020 Results - Earnings Call Transcript

Syros Pharmaceuticals, Inc. (SYRS) Q2 2020 Results Conference Call August 06, 2020 08:30 AM ET Company Participants Naomi Aoki - IR Nancy Simonian - CEO Joe Ferra - CFO David Roth - CMO Conference Call Participants Phil Nadeau - Cowen and Company Ted Tenthoff - Piper Sandler Jason Butler -...

SA Transcripts on Seeking Alpha | August 8, 2020

Read More 'SYRS' Stories Here

SYRS Price Returns

1-mo -28.30%
3-mo -13.00%
6-mo 54.64%
1-year -11.91%
3-year -39.75%
5-year N/A
YTD 32.71%
2019 24.06%
2018 -42.75%
2017 -19.98%
2016 N/A
2015 N/A

Continue Researching SYRS

Want to see what other sources are saying about Syros Pharmaceuticals Inc's financials and stock price? Try the links below:

Syros Pharmaceuticals Inc (SYRS) Stock Price | Nasdaq
Syros Pharmaceuticals Inc (SYRS) Stock Quote, History and News - Yahoo Finance
Syros Pharmaceuticals Inc (SYRS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6954 seconds.